47
Ensho Therapeutics raises $15.6M in biotech funding round
Company raise · Raising · Offering $15.6M · Sold $7.3M · WOODCLIFF LAKE, NJ · filed 2026-10-15
47
Ensho Therapeutics, Inc. raises $20M under Reg D
Company raise · Pre-first close · WOODCLIFF LAKE, NJ · Form D filed 2026-02-09
$10M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Carlos Solorzano | Director |
| Danielle Fry | Executive Officer |
| Gerhard Hagn | Executive Officer |
| Eric Pham | Director |
| Arash Rassoulpour | Director |
Signed by Danielle Fry, Chief Legal Officer & Chief Operating Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
47
Ensho Therapeutics, Inc. raises $22.5M under Reg D
Company raise · Closed · Offering $22.5M · Sold $22.5M · MORRIS PLAINS, NY · filed 2025-09-12
52
Ensho Therapeutics, Inc. raises $5M under Reg D
Company raise · Raising · Offering $12.5M · Sold $5M · MORRIS PLAINS, NY · filed 2024-11-12